Revenue guidance from OptiBiotix as it eyes NASDAQ listing

OptiBiotix Health (LON:OPTI) provides a commercial progress update, explaining why in their financials some items are separated.
CEO Stephen O'Hara tells Proactive London what's behind his thinking adding that Optibiotix hopes to reach profitability in 2020.
News here too on Sweetbiotix and just how serious O'Hara is about market listing on NASDAQ. The firm, which is now in 24 countries, is looking to extend its reach into new application areas such as hypertension, immune health and gut health.

weight loss,diabetes,health,microbiome,